| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1447269
[patent_doc_number] => 06369198
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-09
[patent_title] => 'Allelic variant of human STAT3'
[patent_app_type] => B1
[patent_app_number] => 09/526542
[patent_app_country] => US
[patent_app_date] => 2000-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 9740
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/369/06369198.pdf
[firstpage_image] =>[orig_patent_app_number] => 09526542
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/526542 | Allelic variant of human STAT3 | Mar 15, 2000 | Issued |
| 09/523271 | Deglycosylated ricin toxin A-chain vaccine | Mar 9, 2000 | Abandoned |
Array
(
[id] => 4348294
[patent_doc_number] => 06284881
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-04
[patent_title] => 'Feline Fc epsilon receptor alpha chain nucleic acid molecules'
[patent_app_type] => 1
[patent_app_number] => 9/515431
[patent_app_country] => US
[patent_app_date] => 2000-02-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26791
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/284/06284881.pdf
[firstpage_image] =>[orig_patent_app_number] => 515431
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/515431 | Feline Fc epsilon receptor alpha chain nucleic acid molecules | Feb 28, 2000 | Issued |
Array
(
[id] => 4326178
[patent_doc_number] => 06329340
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-11
[patent_title] => 'Human Defensin DEF-X'
[patent_app_type] => 1
[patent_app_number] => 9/486580
[patent_app_country] => US
[patent_app_date] => 2000-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 17
[patent_no_of_words] => 10786
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/329/06329340.pdf
[firstpage_image] =>[orig_patent_app_number] => 486580
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/486580 | Human Defensin DEF-X | Feb 24, 2000 | Issued |
Array
(
[id] => 1420839
[patent_doc_number] => 06503509
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-01-07
[patent_title] => 'Method for receptor desensitization'
[patent_app_type] => B1
[patent_app_number] => 09/513024
[patent_app_country] => US
[patent_app_date] => 2000-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 15
[patent_no_of_words] => 21584
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/503/06503509.pdf
[firstpage_image] =>[orig_patent_app_number] => 09513024
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/513024 | Method for receptor desensitization | Feb 24, 2000 | Issued |
| 09/510646 | AN ANTIBODY CAPABLE OF INHIBITING T-CELL STIMULATION THROUGH A TIRC7 MEMBRANE PROTEIN AND USES THEREOF | Feb 22, 2000 | Abandoned |
| 09/507150 | Human ctla-8 and uses of ctla-8-related proteins | Feb 17, 2000 | Abandoned |
| 09/498598 | Methods for human allografting | Feb 3, 2000 | Abandoned |
Array
(
[id] => 1178885
[patent_doc_number] => 06743903
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-06-01
[patent_title] => 'Nucleic acids for the diagnosis and treatment of giant cell arteritis'
[patent_app_type] => B1
[patent_app_number] => 09/484577
[patent_app_country] => US
[patent_app_date] => 2000-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 39039
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/743/06743903.pdf
[firstpage_image] =>[orig_patent_app_number] => 09484577
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/484577 | Nucleic acids for the diagnosis and treatment of giant cell arteritis | Jan 17, 2000 | Issued |
| 09/483951 | Anti-ccr4 antibodies and methods of use therefor | Jan 13, 2000 | Abandoned |
Array
(
[id] => 1361858
[patent_doc_number] => 06573372
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-06-03
[patent_title] => 'Feline immunoglobulin E molecules and compositions there of'
[patent_app_type] => B2
[patent_app_number] => 09/479614
[patent_app_country] => US
[patent_app_date] => 2000-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29770
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/573/06573372.pdf
[firstpage_image] =>[orig_patent_app_number] => 09479614
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/479614 | Feline immunoglobulin E molecules and compositions there of | Jan 6, 2000 | Issued |
Array
(
[id] => 1433453
[patent_doc_number] => 06340743
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-22
[patent_title] => 'Antibodies to PIGR stalk'
[patent_app_type] => B1
[patent_app_number] => 09/475088
[patent_app_country] => US
[patent_app_date] => 1999-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10160
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/340/06340743.pdf
[firstpage_image] =>[orig_patent_app_number] => 09475088
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/475088 | Antibodies to PIGR stalk | Dec 29, 1999 | Issued |
Array
(
[id] => 1240758
[patent_doc_number] => 06682736
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-01-27
[patent_title] => 'Human monoclonal antibodies to CTLA-4'
[patent_app_type] => B1
[patent_app_number] => 09/472087
[patent_app_country] => US
[patent_app_date] => 1999-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 62
[patent_no_of_words] => 53085
[patent_no_of_claims] => 104
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/682/06682736.pdf
[firstpage_image] =>[orig_patent_app_number] => 09472087
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/472087 | Human monoclonal antibodies to CTLA-4 | Dec 22, 1999 | Issued |
| 09/471774 | HETERODIMERIC CLASS II CYTOKINE RECEPTOR | Dec 22, 1999 | Abandoned |
Array
(
[id] => 1536364
[patent_doc_number] => 06337316
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-08
[patent_title] => 'Pharmaceutical compositions thereof, and methods of using same'
[patent_app_type] => B1
[patent_app_number] => 09/460384
[patent_app_country] => US
[patent_app_date] => 1999-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12188
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/337/06337316.pdf
[firstpage_image] =>[orig_patent_app_number] => 09460384
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/460384 | Pharmaceutical compositions thereof, and methods of using same | Dec 12, 1999 | Issued |
Array
(
[id] => 4325092
[patent_doc_number] => 06319675
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-20
[patent_title] => 'Methods for detecting and/or identifying agents which bind and/or modulate function of \"bonzo\" chemokine receptor'
[patent_app_type] => 1
[patent_app_number] => 9/449437
[patent_app_country] => US
[patent_app_date] => 1999-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 100
[patent_no_of_words] => 28023
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 209
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/319/06319675.pdf
[firstpage_image] =>[orig_patent_app_number] => 449437
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/449437 | Methods for detecting and/or identifying agents which bind and/or modulate function of "bonzo" chemokine receptor | Nov 23, 1999 | Issued |
Array
(
[id] => 1467874
[patent_doc_number] => 06458934
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-01
[patent_title] => 'Humanized antibody specific for human 4-1BB'
[patent_app_type] => B1
[patent_app_number] => 09/438954
[patent_app_country] => US
[patent_app_date] => 1999-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 18
[patent_no_of_words] => 9731
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/458/06458934.pdf
[firstpage_image] =>[orig_patent_app_number] => 09438954
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/438954 | Humanized antibody specific for human 4-1BB | Nov 11, 1999 | Issued |
| 09/424190 | INHIBITION OF LFA-1/ICAM-2 DEPENDENT LEUKEMIC CELL AGGREGATION | Nov 3, 1999 | Abandoned |
| 09/403815 | HUMAN TUMOR NECROSIS FACTOR RECEPTOR-LIKE 2 (TR2) ANTIBODIES | Oct 25, 1999 | Abandoned |
| 09/403558 | INTEGRIN LIGAND, HUMAN MINDIN | Oct 24, 1999 | Abandoned |
